↓ Skip to main content

Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia

Overview of attention for article published in Orphanet Journal of Rare Diseases, November 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
27 Mendeley